Antifolate Drugs in Cancer Therapy - download pdf or read online

By Robert C. Jackson (auth.), Ann L. Jackman (eds.)

ISBN-10: 0896034607

ISBN-13: 9780896034600

ISBN-10: 1475745214

ISBN-13: 9781475745214

ISBN-10: 1592597254

ISBN-13: 9781592597253

In Antifolate medications in melanoma treatment, Ann Jackman and a panel of very popular researchers comprehensively evaluate the present prestige of novel antifolates, a big classification of anticancer medications. the prestigious members talk about the preclinical and scientific pharmacology of methotrexate, different dihydrofolate reductase inhibitors,
5-fluorouracil, and the hot new release of antifolates-the thymidylate synthase and glycinamide ribonucleotide formyltransferase inhibitors. additionally, they overview intensive the modulation of antifolate medicinal drugs, folate and antifolate delivery mechanisms, polyglutamation, resistance, and drug combos, in addition to pharmacogenomics, pharmacodynamics, legislation of gene expression, and mechanisms of mobilephone loss of life.

The extensive and revolutionary scope of Antifolate medicines in melanoma remedy presents entré to interesting new avenues for destiny study, and constitutes a brand new general reference for all uncomplicated scientists and clinicians engaged in melanoma therapeutics.

Show description

Read Online or Download Antifolate Drugs in Cancer Therapy PDF

Best cancer books

New PDF release: Targeted therapies in cancer : with 25 tables

From its advent, oncological chemotherapy has been weighted down by way of bad selectivity simply because antiproliferative medications are usually poisonous not just to tumor cells but additionally to special populations of the body’s non-neoplastic cells. smooth exact treatments have interaction with outlined molecules current on melanoma cells, including elevated selectivity to their poisonous results.

Download PDF by William C. Raschke (auth.), Stewart Sell, Britta Wahren: Human Cancer Markers

The facility to diagnose melanoma by way of uncomplicated size of a serum or tissue' 'marker" has been a objective of clinical technological know-how for a few years. there's abundant proof that tumor cells are varied from general cells and professional­ duce elements that may be detected via presently on hand immuno­ chemical or biochemical equipment.

Chemotherapy: Volume 7 Cancer Chemotherapy I by Emil Frei III (auth.), K. Hellmann, T. A. Connors (eds.) PDF

The foreign Society of Chemotherapy meets each years to study development in chemotherapy of infections and of malignant sickness. every one assembly will get greater to surround the extension of chemotherapy into new parts. In a few situations, enlargement has been speedy, for instance in cephalosporins, pen­ icillins and mixture chemotherapy of melanoma - in others sluggish, as within the box of parasitology.

Additional resources for Antifolate Drugs in Cancer Therapy

Sample text

In contrast to the DC portion of the cytosolic trifunctional enzyme complex, it has an absolute requirement for Mg2+ and Pi (80). It is proposed that Mg2+ and Pi substitute for the 2' phosphate on the adenosine portion of NADPH because it has a 44% amino acid sequence identity with the DC domain of yeast mitochondrial NADP-dependent trifunc- 24 Kisliuk tional enzyme, the human NAD-dependent enzyme has a low, Mg 2 + -dependent turnover with NADP, and PI competes for NADP binding. Kinetic studies provide an explanation of the mechanism by which the mitochondrial NAD-dependent DC enzyme functions to convert 5,10-CHr H4 PteGlu n to lO-CHOH4PteGlu n, whereas the cytosolic NADP-dependent enzyme functions in the reverse direction (78).

J Biol Chern 1997;272: 19,880-19,883. 109. Johnson M, Yang HS, Johanning GL, Patel MS. Characterization of the mouse dihydrolipoamide dehydrogenase (Dld) gene: genOinic structure, promoter sequence, and chromosomallocalization. Genornics 1997;41:320--326. 110. Mabrouk GM, Bronsan JT. Activation of the hepatic glycine eleavage system by glucagon and glucagon-related peptides. Can J Physiol PharmacoI1997;75:1096-1100. 111. Kure S, Tada K, Narisawa K. Nonketotic hyperglycinemia: biochemical molecular and neurological aspects.

J Biol Chern 1997;272:3628-3634. 19. Ludwig ML, Matthews RG. Structure-based perspectives on B 12-dependent enzymes. Annu Rev Bioehern 1997;66:269-313. 20. Gulati S, Chen, ZQ, Brody LC, Rosenblatt DS, Banerjee R. Defects in auxiliary redox proteins lead to functional methionine synthase deficiency. J Biol Chern 1997;272:19,171-19,175. 21. Abels J, Kroes ACM, Ermens AAM, van Kape1 J, Schoester M, Spijkers LJM, Lindemans J. Antileukemic potential of methyl-cobalamin inactivation by nitrous oxide.

Download PDF sample

Antifolate Drugs in Cancer Therapy by Robert C. Jackson (auth.), Ann L. Jackman (eds.)

by Edward

Rated 4.70 of 5 – based on 23 votes